Uranium Sales The Company made no uranium sales during Q3 CY2023. At 30 September 2023, the Company’s committed sales contracts amounted to 4.8million pounds U3O8 and 0.15 million pounds U3O8 for sales optional at the election of the customers. Delivery is between now and the end of 2034. Sales under existing contracts with major utilities in both United States and Europe comprise up to 34% of the Ross & Kendrick LoM planned production. Due to the re-start of production at Lance shifting to December 2024, Company produced uranium will not be available to meet nearer term delivery commitments. The Company has held discussions with its customer base to address recent developments regarding production plans and implications for scheduled deliveries in CY2023 and CY2024. Agreement with existing customers is well advanced, to align delivery schedules with forecast production in support of the Lance restart. Uranium Inventory The Company has a balance of 210,000 pounds U3O8 inventory. The inventory is expected to be monetised by satisfying nearer term offtake requirements alongside finalisation of agreement with customers to re-align the delivery schedule with forecast production.
PEN Price at posting:
12.0¢ Sentiment: Sell Disclosure: Not Held
